Product Reports Resources Pricing Login Book a demo

andros

Health · New York City, United States · Founded 2013

Andros is a cutting-edge technology company specializing in advanced solutions for the life sciences and healthcare sectors. With a focus on improving clinical trial management and patient care, Andros offers an integrated platform that enhances data collection, patient engagement, and operational efficiency. Their flagship product, Andros, is designed to streamline the complex processes of clinical trials by providing a comprehensive digital ecosystem. This platform supports a range of functionalities including real-time data capture, patient recruitment, and remote monitoring, ensuring a more efficient and effective trial management process. By leveraging innovative technology, Andros aims to reduce the administrative burden on researchers and improve the overall quality of clinical research. In addition to its core offerings, Andros is committed to advancing the field of healthcare through continuous innovation. The company’s solutions are built with a user-centric approach, prioritizing ease of use and integration with existing systems to facilitate smoother transitions and minimize disruptions. Their technology supports various aspects of clinical trials and patient management, contributing to more accurate results and better patient outcomes. Andros also places a strong emphasis on data security and compliance, ensuring that all processes adhere to the highest standards of privacy and regulatory requirements. Their commitment to excellence is reflected in their ongoing efforts to refine and enhance their technology, positioning Andros as a leader in the digital transformation of healthcare and clinical research.

Valuation $0–100M
Revenue $10–50M
Headcount 100–500
Total funding $50–100M
Unlock exact values This page shows ranges. Dealroom has the exact numbers for andros and the history behind them.

Investors

10 investors on andros's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 4 investors entered at this stage
Series A 5 investors entered at this stage
Windham Venture Partners
Newark Venture Partners
Meridian Street Capital
Primary Ventures
Questa Capital Management
Series B+ 1 investor entered at this stage
Healthy Ventures

Global footprint

Where andros has talent and traffic

Workforce by country
3 countries with
team presence
🇺🇸 United States97.5%
🏳️ Bahamas1.3%
🇧🇷 Brazil1.3%
3 countries shown
Web traffic by country
40 monthly visits
across markets
🇺🇸 United States0%
Top 1 markets shown

Talent graph

The shape of andros's talent

Dealroom maps andros's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

30 standout operatorsDealroom-flagged across the org
1 AI specialistpinpointed by name
106 employees mappedperson by person
DimensionScore
AI Talentlive Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock andros's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about andros

An AI-synthesized read of the highest-engagement posts about andros on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See andros on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.